Sanofi’s Fluzone High-Dose approved in Canada
TORONTO — Health Canada has approved Sanofi Pasteur’s Fluzone High-Dose influenza vaccine developed for adults age 65 and older. A trivalent vaccine, Fluzone High-Dose contains four times the amount of hemagglutinin (HA) per strain versus a standard dose vaccine and is administered as a single, 0.5 ml intramuscular injection. The higher-dose flu shot, which already has
